{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:25Z","timestamp":1787003725299,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"King Saud University, Riyadh, Saudi Arabia","award":["RSPD2025R709"],"award-info":[{"award-number":["RSPD2025R709"]}]},{"name":"King Saud University, Riyadh, Saudi Arabia","award":["RSPD2025R709"],"award-info":[{"award-number":["RSPD2025R709"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11592-9","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:24:21Z","timestamp":1752621861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["System biology-based assessment of the molecular mechanism of epigallocatechin gallate in Parkinson\u2019s disease: via network pharmacology, in-silico evaluation & in-vitro studies"],"prefix":"10.1038","volume":"15","author":[{"given":"Hannah Lalengzuali","family":"Fanai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh F.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabry M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha Bin","family":"Emran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"11592_CR1","doi-asserted-by":"publisher","DOI":"10.7324\/JAPS.2020.1010015","author":"ES Abdel-Nasser","year":"2020","unstructured":"Abdel-Nasser, E. S., Sachin, C., Khadeja, A. A., Razan, F. A. & Fatma, Y. A. A comprehensive review on management of Parkinson\u2019s disease, inclusive of drug discovery and pharmacological approaches. J. Appl. Pharm. Sci. https:\/\/doi.org\/10.7324\/JAPS.2020.1010015 (2020).","journal-title":"J. Appl. Pharm. Sci."},{"key":"11592_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.5530\/ijper.57.2.68","volume":"57","author":"G Subramanian","year":"2023","unstructured":"Subramanian, G., Chand, J., Jupudi, S. & Prudviraj, P. Synthesis and biological evaluation of the selected naphthalene substituted azetidinone derivatives targeting Parkinson\u2019s disease. Ind. J. Pharm. Edu. Res. 57, 552\u2013558 (2023).","journal-title":"Ind. J. Pharm. Edu. Res."},{"key":"11592_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105799","volume":"115","author":"CK Bhusal","year":"2023","unstructured":"Bhusal, C. K. et al. Unveiling nature\u2019s potential: Promising natural compounds in Parkinson\u2019s disease management. Parkinsonism Relat. Disord. 115, 105799 (2023).","journal-title":"Parkinsonism Relat. Disord."},{"key":"11592_CR4","doi-asserted-by":"publisher","first-page":"6680935","DOI":"10.1155\/2021\/6680935","volume":"2021","author":"R Balakrishnan","year":"2021","unstructured":"Balakrishnan, R., Azam, S., Cho, D.-Y., Su-Kim, I. & Choi, D.-K. Natural phytochemicals as novel therapeutic strategies to prevent and treat Parkinson\u2019s disease: Current knowledge and future perspectives. Oxid. Med. Cell. Longev. 2021, 6680935 (2021).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"11592_CR5","doi-asserted-by":"publisher","DOI":"10.34172\/apb.2021.026","author":"MR Khazdair","year":"2020","unstructured":"Khazdair, M. R., Kianmehr, M. & Anaeigoudari, A. Effects of medicinal plants and flavonoids on Parkinson\u2019s Disease, a review on basic and clinical evidences. Adv. Pharm. Bull. https:\/\/doi.org\/10.34172\/apb.2021.026 (2020).","journal-title":"Adv. Pharm. Bull."},{"key":"11592_CR6","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3390\/molecules14020738","volume":"14","author":"E Szliszka","year":"2009","unstructured":"Szliszka, E. et al. Ethanolic extract of propolis (EEP) enhances the apoptosis- inducing potential of TRAIL in cancer cells. Molecules 14, 738\u2013754 (2009).","journal-title":"Molecules"},{"key":"11592_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3389\/fphar.2018.00757","volume":"9","author":"SS Singh","year":"2018","unstructured":"Singh, S. S. et al. Effect of chlorogenic acid supplementation in MPTP-intoxicated mouse. Front. Pharmacol. 9, 757 (2018).","journal-title":"Front. Pharmacol."},{"key":"11592_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.phrs.2015.12.027","volume":"104","author":"MRD Oliveira","year":"2016","unstructured":"Oliveira, M. R. D., Nabavi, S. F., Daglia, M., Rastrelli, L. & Nabavi, S. M. Epigallocatechin gallate and mitochondria\u2014a story of life and death. Pharmacol. Res. 104, 70\u201385 (2016).","journal-title":"Pharmacol. Res."},{"key":"11592_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101466","volume":"55","author":"V S\u00e1nchez-Giraldo","year":"2020","unstructured":"S\u00e1nchez-Giraldo, V. et al. Role of a novel (\u2212)-epigallocatechin-3-gallate delivery system on the prevention against oxidative stress damage in vitro and in vivo model of Parkinson\u2019s disease. J. Drug Deliv. Sci. Technol. 55, 101466 (2020).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"11592_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.977521","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson\u2019s disease. Front. Pharmacol. 13, 977521 (2022).","journal-title":"Front. Pharmacol."},{"key":"11592_CR11","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1021\/acs.jafc.0c07658","volume":"69","author":"S Luo","year":"2021","unstructured":"Luo, S. et al. Enhanced neuroprotective effects of epicatechin gallate encapsulated by bovine milk-derived exosomes against Parkinson\u2019s disease through antiapoptosis and antimitophagy. J. Agric. Food Chem. 69, 5134\u20135143 (2021).","journal-title":"J. Agric. Food Chem."},{"key":"11592_CR12","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s11064-020-03058-3","volume":"45","author":"A Singh","year":"2020","unstructured":"Singh, A., Tripathi, P., Yadawa, A. K. & Singh, S. Promising polyphenols in Parkinson\u2019s disease therapeutics. Neurochem Res 45, 1731\u20131745 (2020).","journal-title":"Neurochem Res"},{"key":"11592_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202403494","author":"J Chand","year":"2025","unstructured":"Chand, J. et al. Exploring cannabidiol\u2013TRPV3 mediated biological activities\u2014findings from molecular docking, simulation and proteins network interactions. Chem. Biodivers. https:\/\/doi.org\/10.1002\/cbdv.202403494 (2025).","journal-title":"Chem. Biodivers."},{"key":"11592_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/1028415X.2018.1500124","volume":"23","author":"AR Khalatbary","year":"2020","unstructured":"Khalatbary, A. R. & Khademi, E. The green tea polyphenolic catechin epigallocatechin gallate and neuroprotection. Nutr. Neurosci. 23, 281\u2013294 (2020).","journal-title":"Nutr. Neurosci."},{"key":"11592_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/bcpt.13426","volume":"127","author":"L Liberale","year":"2020","unstructured":"Liberale, L., Kraler, S., Camici, G. G. & L\u00fcscher, T. F. Ageing and longevity genes in cardiovascular diseases. Basic Clin Pharma Tox 127, 120\u2013131 (2020).","journal-title":"Basic Clin Pharma Tox"},{"key":"11592_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12640-019-00143-6","volume":"37","author":"H-C Tseng","year":"2020","unstructured":"Tseng, H.-C. et al. Protective effect of (\u2212)epigallocatechin-3-gallate on rotenone-induced Parkinsonism-like symptoms in rats. Neurotox Res 37, 669\u2013682 (2020).","journal-title":"Neurotox Res"},{"key":"11592_CR17","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1016\/j.csbj.2020.11.015","volume":"18","author":"C Wang","year":"2020","unstructured":"Wang, C., Chen, L., Zhang, M., Yang, Y. & Wong, G. PDmethDB: A curated Parkinson\u2019s disease associated methylation information database. Comput. Struct. Biotechnol. J. 18, 3745\u20133749 (2020).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"11592_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104562","volume":"135","author":"D Jin","year":"2021","unstructured":"Jin, D. et al. Network pharmacology-based and molecular docking prediction of the active ingredients and mechanism of ZaoRenDiHuang capsules for application in insomnia treatment. Comput. Biol. Med. 135, 104562 (2021).","journal-title":"Comput. Biol. Med."},{"key":"11592_CR19","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"11592_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.33263\/BRIAC142.027","volume":"14","author":"ZM Mohammad","year":"2024","unstructured":"Mohammad, Z. M. et al. Investigation of Scutellaria baicalensis for potential neuroprotective effect on the treatment of Parkinson\u2019s disease. Biointerface Res Appl Chem 14, 27 (2024).","journal-title":"Biointerface Res Appl Chem"},{"key":"11592_CR21","doi-asserted-by":"publisher","first-page":"1029637","DOI":"10.3389\/fnagi.2022.1029637","volume":"14","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Bioinformatics analysis of gene expression profile and functional analysis in periodontitis and Parkinson\u2019s disease. Front. Aging Neurosci. 14, 1029637 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"11592_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.33263\/BRIAC142.048","volume":"14","author":"G Subramanian","year":"2024","unstructured":"Subramanian, G. Network pharmacology approach and molecular docking prediction to investigate the possible mechanism of benzylidene derivatives against scavenging reactive oxygen species via sirtuin 3 in Parkinson\u2019s disease. Biointerface Res Appl Chem 14, 48 (2024).","journal-title":"Biointerface Res Appl Chem"},{"key":"11592_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.131084","volume":"1245","author":"O Temiz-Arpaci","year":"2021","unstructured":"Temiz-Arpaci, O. et al. Synthesis, quantum mechanical calculations, antimicrobial activities and molecular docking studies of five novel 2,5-disubstituted benzoxazole derivatives. J. Mol. Struct. 1245, 131084 (2021).","journal-title":"J. Mol. Struct."},{"key":"11592_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1055\/a-2231-1311","volume":"74","author":"G Subramanian","year":"2024","unstructured":"Subramanian, G., Prasad, K., Chand, J., Amarjith, T. K. & Shanish, A. A. In-silico, synthesis, characterization, and in-vitro studies on benzylidene-based 2-chloroquinolin derivatives as free radical scavengers in Parkinson\u2019s disease. Drug Res (Stuttg) 74, 67\u201376 (2024).","journal-title":"Drug Res (Stuttg)"},{"key":"11592_CR25","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu, C. et al. OPLS4: Improving force field accuracy on challenging regimes of chemical space. J. Chem. Theory Comput. 17, 4291\u20134300 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"11592_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s13659-020-00260-2","volume":"10","author":"P Khanal","year":"2020","unstructured":"Khanal, P., Patil, B. M., Chand, J. & Naaz, Y. Anthraquinone derivatives as an immune booster and their therapeutic option against COVID-19. Nat. Prod. Bioprospect. 10, 325\u2013335 (2020).","journal-title":"Nat. Prod. Bioprospect."},{"key":"11592_CR27","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/antiox11091745","volume":"11","author":"J Qiu","year":"2022","unstructured":"Qiu, J. et al. NADPH oxidase mediates oxidative stress and ventricular remodeling through SIRT3\/FOXO3a pathway in diabetic mice. Antioxidants 11, 1745 (2022).","journal-title":"Antioxidants"},{"key":"11592_CR28","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1080\/07391102.2020.1753580","volume":"39","author":"P Sarma","year":"2021","unstructured":"Sarma, P. et al. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). J. Biomol. Struct. Dyn. 39, 2724\u20132732 (2021).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"11592_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/15384047.2020.1842705","volume":"22","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. CXCL6 regulates cell permeability, proliferation, and apoptosis after ischemia\u2013reperfusion injury by modulating Sirt3 expression via AKT\/FOXO3a activation. Cancer Biol. Ther. 22, 30\u201339 (2021).","journal-title":"Cancer Biol. Ther."},{"key":"11592_CR30","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.4103\/1673-5374.282264","volume":"15","author":"S Zhang","year":"2020","unstructured":"Zhang, S., Ma, Y. & Feng, J. Neuroprotective mechanisms of \u03b5-viniferin in a rotenone-induced cell model of Parkinson\u2019s disease: significance of SIRT3-mediated FOXO3 deacetylation. Neural Regen Res 15, 2143 (2020).","journal-title":"Neural Regen Res"},{"key":"11592_CR31","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1080\/07391102.2020.1782266","volume":"39","author":"GE Mathew","year":"2021","unstructured":"Mathew, G. E. et al. Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson\u2019s disease. J. Biomol. Struct. Dyn. 39, 4786\u20134794 (2021).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"11592_CR32","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/slct.201904655","volume":"5","author":"VK Madduluri","year":"2020","unstructured":"Madduluri, V. K. & Sah, A. K. Synthesis of mefenamic acid containing N-glycoconjugates and their evaluation as human COX-2 enzyme inhibitor. ChemistrySelect 5, 2197\u20132200 (2020).","journal-title":"ChemistrySelect"},{"key":"11592_CR33","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1080\/07391102.2023.2283161","volume":"43","author":"Aryan","year":"2025","unstructured":"Aryan, et al. Rational design of thiazolidine-4-one-gallic acid hybrid derivatives as selective partial PPAR\u03b3 modulators: an in-silico approach for type 2 diabetes treatment. J. Biomol. Struct. Dyn. 43, 694\u2013708 (2025).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"11592_CR34","first-page":"8","volume":"5","author":"KY Raheem","year":"2023","unstructured":"Raheem, K. Y. et al. Therapeutic capability of selected medicinal plants\u2019 bioactive constituents against the mutant ovarian TP53 gene; a computational approach. Adv. Biomark. Sci. Technol. 5, 8\u201332 (2023).","journal-title":"Adv. Biomark. Sci. Technol."},{"key":"11592_CR35","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1007\/s11172-017-1954-x","volume":"66","author":"DS Druzhilovskiy","year":"2017","unstructured":"Druzhilovskiy, D. S. et al. Computational platform Way2Drug: From the prediction of biological activity to drug repurposing. Russ Chem Bull 66, 1832\u20131841 (2017).","journal-title":"Russ Chem Bull"},{"key":"11592_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55\u201363 (1983).","journal-title":"J. Immunol. Methods"},{"key":"11592_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40011-019-01122-9","volume":"90","author":"C Jerard","year":"2020","unstructured":"Jerard, C., Michael, B. P., Chenicheri, S., Vijayakumar, N. & Ramachandran, R. Rosmarinic acid-rich fraction from Mentha arvensis synchronizes Bcl\/Bax expression and induces Go\/G1 arrest in hepatocarcinoma cells. Proc. Natl. Acad. Sci. India Sect. B Biol. Sci 90, 515\u2013522 (2020).","journal-title":"Proc. Natl. Acad. Sci. India Sect. B Biol. Sci"},{"key":"11592_CR38","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0003-2697(77)90429-8","volume":"79","author":"HP Misra","year":"1977","unstructured":"Misra, H. P. & Fridovich, I. Superoxide dismutase: \u201cPositive\u201d spectrophotometric assays. Anal. Biochem. 79, 553\u2013560 (1977).","journal-title":"Anal. Biochem."},{"key":"11592_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0278-6915(01)00117-X","volume":"40","author":"SM Barlow","year":"2002","unstructured":"Barlow, S. M. et al. Hazard identification by methods of animal-based toxicology. Food Chem. Toxicol. 40, 145\u2013191 (2002).","journal-title":"Food Chem. Toxicol."},{"key":"11592_CR40","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.3945\/jn.117.255034","volume":"147","author":"Q Xu","year":"2017","unstructured":"Xu, Q., Langley, M., Kanthasamy, A. G. & Reddy, M. B. Epigallocatechin gallate has a neurorescue effect in a mouse model of Parkinson disease. J. Nutr. 147, 1926\u20131931 (2017).","journal-title":"J. Nutr."},{"key":"11592_CR41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.foodchem.2016.08.098","volume":"217","author":"L-G Xiong","year":"2017","unstructured":"Xiong, L.-G. et al. Tea polyphenol epigallocatechin gallate inhibits Escherichia coli by increasing endogenous oxidative stress. Food Chem. 217, 196\u2013204 (2017).","journal-title":"Food Chem."},{"key":"11592_CR42","doi-asserted-by":"publisher","first-page":"32508","DOI":"10.1039\/C7RA03752J","volume":"7","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. (\u2212)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of \u03b1-synuclein, and protects PC12 cells against \u03b1-synuclein-induced toxicity. RSC Adv. 7, 32508\u201332517 (2017).","journal-title":"RSC Adv."},{"key":"11592_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/iub.2542","volume":"74","author":"N Krafczyk","year":"2022","unstructured":"Krafczyk, N. & Klotz, L. FOXO transcription factors in antioxidant defense. IUBMB Life 74, 53\u201361 (2022).","journal-title":"IUBMB Life"},{"key":"11592_CR44","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4155\/fmc-2017-0204","volume":"10","author":"W Shi","year":"2018","unstructured":"Shi, W. et al. The critical role of epigallocatechin gallate in regulating mitochondrial metabolism. Future Med. Chem. 10, 795\u2013809 (2018).","journal-title":"Future Med. Chem."},{"key":"11592_CR45","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41419-022-05343-1","volume":"13","author":"J Sarkar","year":"2022","unstructured":"Sarkar, J. et al. Epigallocatechin-3-gallate inhibits osteoclastic differentiation by modulating mitophagy and mitochondrial functions. Cell Death Dis. 13, 908 (2022).","journal-title":"Cell Death Dis."},{"key":"11592_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2021.104764","volume":"87","author":"F Li","year":"2021","unstructured":"Li, F., Hatano, T. & Hattori, N. Systematic analysis of the molecular mechanisms mediated by coffee in Parkinson\u2019s disease based on network pharmacology approach. J. Funct. Foods 87, 104764 (2021).","journal-title":"J. Funct. Foods"},{"key":"11592_CR47","doi-asserted-by":"publisher","first-page":"13154","DOI":"10.1038\/s41598-021-92701-2","volume":"11","author":"P Quan","year":"2021","unstructured":"Quan, P. et al. Integrated network analysis identifying potential novel drug candidates and targets for Parkinson\u2019s disease. Sci. Rep. 11, 13154 (2021).","journal-title":"Sci. Rep."},{"key":"11592_CR48","doi-asserted-by":"publisher","first-page":"23414","DOI":"10.1038\/s41598-024-75603-x","volume":"14","author":"G Subramanian","year":"2024","unstructured":"Subramanian, G. et al. System biology-based assessment of the molecular mechanism of IMPHY000797 in Parkinson\u2019s disease: A network pharmacology and in-silico evaluation. Sci. Rep. 14, 23414 (2024).","journal-title":"Sci. Rep."},{"key":"11592_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.714463","volume":"8","author":"W Ruankham","year":"2022","unstructured":"Ruankham, W. et al. Modulatory effects of alpha-mangostin mediated by SIRT1\/3-FOXO3a pathway in oxidative stress-induced neuronal cells. Front. Nutr. 8, 714463 (2022).","journal-title":"Front. Nutr."},{"key":"11592_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101645","volume":"181","author":"W Hu","year":"2019","unstructured":"Hu, W. et al. Roles of forkhead box O (FoxO) transcription factors in neurodegenerative diseases: A panoramic view. Prog. Neurobiol. 181, 101645 (2019).","journal-title":"Prog. Neurobiol."},{"key":"11592_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.109328","volume":"333","author":"WH Almalki","year":"2021","unstructured":"Almalki, W. H., Alzahrani, A., Mahmoud El-Daly, M.E.-S. & Fadel Ahmed, A.-S.H.F. The emerging potential of SIRT-3 in oxidative stress-inflammatory axis associated increased neuroinflammatory component for metabolically impaired neural cell. Chem. Biol. Interact. 333, 109328 (2021).","journal-title":"Chem. Biol. Interact."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11592-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11592-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11592-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T11:25:17Z","timestamp":1757244317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11592-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11592"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11592-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"12 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25678"}}